Cite
Bagacean C, Tempescul A, Le Dantec C, et al. Alterations in DNA methylation/demethylation intermediates predict clinical outcome in chronic lymphocytic leukemia. Oncotarget. 2017;8(39):65699-65716doi: 10.18632/oncotarget.20081.
Bagacean, C., Tempescul, A., Le Dantec, C., Bordron, A., Mohr, A., Saad, H., Olivier, V., Zdrenghea, M., Cristea, V., Cartron, P. F., Douet-Guilbert, N., Berthou, C., & Renaudineau, Y. (2017). Alterations in DNA methylation/demethylation intermediates predict clinical outcome in chronic lymphocytic leukemia. Oncotarget, 8(39), 65699-65716. https://doi.org/10.18632/oncotarget.20081
Bagacean, Cristina, et al. "Alterations in DNA methylation/demethylation intermediates predict clinical outcome in chronic lymphocytic leukemia." Oncotarget vol. 8,39 (2017): 65699-65716. doi: https://doi.org/10.18632/oncotarget.20081
Bagacean C, Tempescul A, Le Dantec C, Bordron A, Mohr A, Saad H, Olivier V, Zdrenghea M, Cristea V, Cartron PF, Douet-Guilbert N, Berthou C, Renaudineau Y. Alterations in DNA methylation/demethylation intermediates predict clinical outcome in chronic lymphocytic leukemia. Oncotarget. 2017 Aug 09;8(39):65699-65716. doi: 10.18632/oncotarget.20081. eCollection 2017 Sep 12. PMID: 29029465; PMCID: PMC5630365.
Copy
Download .nbib